摘要
目的分析某院门诊麻醉性镇痛药的应用情况。方法以WHO推荐的限定日剂量(DDD)分析方法,统计分析某院2013年~2014年门诊麻醉性镇痛药的处方数、用药频度(DDDs)及用药金额。结果该院门诊2014年麻醉性镇痛药总DDDs值较2013年增长0.7%,销售金额增长6.7%,2013年盐酸羟考酮缓释片(20 mg)DDDs居首位,2014年芬太尼透皮贴剂(8.4 mg)DDDs居首位。结论该院门诊癌性疼痛的治疗剂型选择上以缓控释片剂、透皮贴剂为主,麻醉性镇痛药使用合理。
Objective To analyze the usage of narcotic analgesics in outpatients of tumor hospital.Methods Prescriptions amout,DDDs and consumption sum were analyzed statistically with DDD analysis method.Results The total DDDs value of narcotic analgesics in the hospital in 2014 increased by 0.7% compared with that of 2013, and consumption sum was 6.7% increase.With regard to DDDs,the topping list was oxycodone hydrochloride controlled release tablets(20 mg)in 2013, and fentanyl transdermal patch(8.4 mg) was in 2014.Conclusion Sustained-release tablet and transdermal patch are the top choice of outpatients with cancer pain.The utilization of narcotic analgesics is rational.
出处
《中国处方药》
2015年第10期6-7,共2页
Journal of China Prescription Drug